Free Trial

AngioDynamics (ANGO) SEC Filings & 10K Form

AngioDynamics logo
$7.10 -0.04 (-0.56%)
(As of 12:03 PM ET)

Recent AngioDynamics SEC Filings

DateFilerForm TypeView
10/10/2024
2:22 PM
AngioDynamics (Issuer)
Nighan Warren JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
5:27 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:32 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:08 PM
AngioDynamics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/03/2024
6:30 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
1:57 PM
AngioDynamics (Filer)
Form DEF 14A
09/26/2024
1:59 PM
AngioDynamics (Filer)
Form DEFA14A
08/02/2024
8:55 PM
AngioDynamics (Issuer)
Piccinini Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
8:48 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
8:48 PM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
8:50 PM
AngioDynamics (Issuer)
Nighan Warren JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
8:53 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
8:00 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
8:00 PM
AngioDynamics (Issuer)
Nighan Warren JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
8:00 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
8:00 PM
AngioDynamics (Issuer)
Piccinini Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
8:00 PM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:36 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:01 AM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:01 AM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:01 AM
AngioDynamics (Issuer)
Nighan Warren JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:01 AM
AngioDynamics (Issuer)
Piccinini Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Auen Eileen O'Shea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Licitra Karen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Burgess Lorinda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
DONNELLY HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
JOHNSON WESLEY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Tarnoff Michael E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
REED JAN STERN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Nighan Warren JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:18 PM
AngioDynamics (Issuer)
Piccinini Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
6:22 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
6:15 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
4:08 PM
AngioDynamics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/08/2024
3:30 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
6:30 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
7:49 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:24 PM
AngioDynamics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
01/23/2024
3:14 PM
AngioDynamics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/22/2024
12:31 PM
AngioDynamics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
6:30 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
6:30 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:47 PM
AngioDynamics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/05/2024
6:15 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ANGO) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners